Proteins are an important class of biological macromolecules composed of amino acids present in living organisms. They play a variety of important roles, including participating in the metabolism, transportation, and transmission of nerve impulses in the body in organisms, and they are important molecules necessary to maintain life activities. Peptides are proteins of low molecular weight, usually consisting of less than 50 amino acid residues. Similar to proteins, peptides also play various important biological roles.
Ace Therapeutics offers hundreds of natural and recombinant proteins & peptides for stroke research, including but not limited to, cytokines, neuroprotective proteins, apoptotic factors, and inflammatory mediators.
Importantly, each of our products is verified by standard quality control procedures and tested for biological activity and low endotoxicity.
Please access our all-series proteins & peptides or contact our scientist for personalized assistance.
| Cat.# | Name | Size | Description | Price |
|---|---|---|---|---|
| ACPP-1241 | Dopamine Receptor D4 Blocking Peptide (AC1241) | 250 µg |
Dopamine Receptor D4 Blocking Peptide for Immunodepletion, Immunocompetition
|
inquiry |
| ACPP-1242 | MC3 Receptor Blocking Peptide (AC1242) | 250 µg |
MC3 Receptor Blocking Peptide for Immunodepletion, Immunocompetition
|
inquiry |
| ACPP-1243 | ELOVL4 Blocking Peptide (AC1243) | 250 µg |
ELOVL4 Blocking Peptide for Immunocompetition, Immunodepletion
|
inquiry |
| ACPP-1244 | SOX2 Blocking Peptide (AC1244) | 250 µg |
SOX2 Blocking Peptide for Immunodepletion, Immunocompetition
|
inquiry |
| ACPP-1245 | CRMP2 Blocking Peptide (AC1245) | 250 µg |
CRMP2 Blocking Peptide for Immunocompetition, Immunodepletion
|
inquiry |
| ACPP-1246 | Bestrophin Blocking Peptide (AC1246) | 250 µg |
Bestrophin Blocking Peptide for Immunodepletion, Immunocompetition
|
inquiry |
| ACPP-1247 | GSK3 beta Blocking Peptide (AC1247) | 250 µg |
GSK3 beta Blocking Peptide for Immunocompetition, Immunodepletion
|
inquiry |
| ACPP-1248 | Mitofusin 2 Blocking Peptide (AC1248) | 250 µg |
Mitofusin 2 Blocking Peptide for Immunocompetition, Immunodepletion
|
inquiry |
| ACPP-1249 | TMPRSS2 Blocking Peptide (AC1249) | 250 µg |
TMPRSS2 Blocking Peptide for Immunocompeition, Immunodepletion
|
inquiry |
| ACPP-1250 | Lin28 Blocking Peptide (AC1250) | 250 µg |
Lin28 Blocking Peptide for Immunodepletion, Immunocompetition
|
inquiry |
| ACPP-1251 | EAAT2 Blocking Peptide (AC1251) | 250 µg |
EAAT2 Blocking Peptide for Immunocompetition, Immunodepletion
|
inquiry |
| ACPP-1252 | Robo3 Blocking Peptide (AC1252) | 250 µg |
Robo3 Blocking Peptide for Immunodepletion, Immunocompetition
|
inquiry |
| ACPP-1253 | Pin1 Blocking Peptide (AC1253) | 250 µg |
Pin1 Blocking Peptide for Immunocompetition, Immunodepletion
|
inquiry |
| ACPP-1254 | Luteinizing Hormone Blocking Peptide (AC1254) | 250 µg |
Luteinizing Hormone Blocking Peptide for Immunodepletion, Immunocompetition
|
inquiry |
| ACPP-1255 | MC3 Receptor Blocking Peptide (AC1255) | 250 µg |
MC3 Receptor Blocking Peptide for Immunodepletion, Immunocompetition
|
inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.